Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors

High Blood Press Cardiovasc Prev. 2014 Jun;21(2):81-7. doi: 10.1007/s40292-014-0054-3. Epub 2014 May 13.

Abstract

The worldwide prevalence of obesity has nearly doubled, with an increase in obesity-related cardiovascular disease and mortality. Several factors are involved in the genesis of hypertension and hypertensive heart disease (HHD) in overweight/obesity. This review is focused on bridging factors between excessive adiposity and HHD, presenting a unifying hypothesis of vascular-metabolic syndrome, where an "handicap" of the natriuretic peptide system has a central role both in adipocyte dysmetabolism as well as in increased blood pressure and HHD.

Publication types

  • Review

MeSH terms

  • Adiposity
  • Animals
  • Blood Pressure
  • Comorbidity
  • Heart Diseases / epidemiology
  • Heart Diseases / metabolism
  • Heart Diseases / physiopathology*
  • Hemodynamics*
  • Humans
  • Hypertension / epidemiology
  • Hypertension / metabolism
  • Hypertension / physiopathology*
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / physiopathology
  • Natriuretic Peptides / metabolism
  • Obesity / epidemiology
  • Obesity / metabolism
  • Obesity / physiopathology*
  • Prevalence
  • Renin-Angiotensin System
  • Risk Factors
  • Signal Transduction

Substances

  • Natriuretic Peptides